Search - tctmd.com

Displaying 421 - 440 of 664

Sort: Relevancy | Date

Presentation LAA 2014

Assessing LAA Morphology and Size for Device Selection: Role of CT

Presenter: John D. Carroll

July 19, 2014

Presentation LAA 2014

Watchman: Registry Data from the “Real-World”

Presenter: Vivek Y. Reddy

July 19, 2014

Presentation LAA 2014

Watchman: Randomized Trial Data in Anticoagulant Eligible Patients(from PROTECT AF to CAP to PREVAIL)

Presenter: David R. Holmes

July 19, 2014

Presentation LAA 2014

Watchman: Non-Randomized Trial Data in Anticoagulant Ineligible Patients ASAP and more

Presenter: Vivek Y. Reddy

July 19, 2014

Presentation LAA 2014

The Afib-LAA Closure Heart Team: Constituents and Process

Presenter: Matthew J. Price

July 19, 2014

Presentation LAA 2014

Outcomes Data with the Amplatzer Cardiac Plug in Anticoagulant Eligible and Ineligible Patients

Presenter: Josep Rod?s-Cabau

July 19, 2014

Presentation LAA 2014

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

Presenter: Maurice Buchbinder

July 19, 2014

Presentation LAA 2014

LARIAT: Clinical Trial Results & Future Trials

Presenter: Steven J. Yakubov

July 19, 2014

Presentation LAA 2014

Case 2: Watchman Implantation

Presenter: Vivek Y. Reddy

July 19, 2014

Presentation LAA 2014

Basic Echo Views for LAA Assessment and Closure Guidance

Presenter: Rebecca T. Hahn

July 19, 2014

Presentation LAA 2014

Atrial Fibrillation in Patient with Low Bleeding Risk

Presenter: John D. Carroll

July 19, 2014

Presentation LAA 2014

Atrial Fibrillation and LAA Closure in a Patient Requiring PCI

Presenter: Matthew J. Price

July 19, 2014

Presentation LAA 2014

An Initial Trial of Pharmacologic Therapy

Presenter: Stefan Bertog

July 19, 2014

Presentation LAA 2014

Afib and LAA Closure in the TAVR Patient

Presenter: George S. Hanzel

July 19, 2014

Presentation LAA 2014

Pericardial Effusions and Tamponade: Pericardial Access

Presenter: Randall J. Lee

July 18, 2014

Presentation LAA 2014

Do We Need More Data for Approving WATCHMAN?

Presenter: Jay N. Koneru

July 18, 2014

Presentation LAA 2014

The case of Watchman Approval

Presenter: Saibal Kar

July 18, 2014

Presentation LAA 2014

Quantifying stroke and bleeding risk in atrial fibrillation

Presenter: Stefan Bertog

July 17, 2014

Presentation LAA 2014

Novel Anticoagulants

Presenter: Michael D. Ezekowitz

July 17, 2014

Presentation LAA 2014

Device-based LAA Closure 2014: From Indications to Worldwide Practice

Presenter: Saibal Kar

July 17, 2014

Advertisement

Assessing LAA Morphology and Size for Device Selection: Role of CT

Watchman: Registry Data from the “Real-World”

Watchman: Randomized Trial Data in Anticoagulant Eligible Patients(from PROTECT AF to CAP to PREVAIL)

Watchman: Non-Randomized Trial Data in Anticoagulant Ineligible Patients ASAP and more

The Afib-LAA Closure Heart Team: Constituents and Process

Outcomes Data with the Amplatzer Cardiac Plug in Anticoagulant Eligible and Ineligible Patients

Left Atrial Appendage Closure (LAAC) for Stroke Prevention in Non-Valvular AFib: My Preferred Frontline Therapy

LARIAT: Clinical Trial Results & Future Trials

Case 2: Watchman Implantation

Basic Echo Views for LAA Assessment and Closure Guidance

Atrial Fibrillation in Patient with Low Bleeding Risk

Atrial Fibrillation and LAA Closure in a Patient Requiring PCI

An Initial Trial of Pharmacologic Therapy

Afib and LAA Closure in the TAVR Patient

Pericardial Effusions and Tamponade: Pericardial Access

Do We Need More Data for Approving WATCHMAN?

The case of Watchman Approval

Quantifying stroke and bleeding risk in atrial fibrillation

Novel Anticoagulants

Device-based LAA Closure 2014: From Indications to Worldwide Practice

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content